TNFSF10 and prostate carcinoma: TRAIL mediated signaling in rearranged prostate cancer cells has not been adequately investigated, and a deeper understanding of the death and decoy receptors in fusion positive prostate cancer cells is essential to testing of synthetic and natural compounds to restore TRAIL mediated signaling in prostate cancer cells.